Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma

Fig. 5

Validate the ability of CRSS to predict the effect of immunotherapy in other CM immunotherapy cohorts. KM analysis was used to compare the difference of immunotherapy effect between high and low CRRS groups in phs000452 (A), PRJEB23709 (D), GSE91061 (G), GSE93157 (J), GSE100797 (M), GSE78220 (P), GSE106128 (R), and Nathanson_2017 (T) dataset. Comparison of CRRS of different CM patients in different remission states after immunotherapy in phs000452 (B), PRJEB23709 (E), GSE91061 (H), GSE93157 (K), and GSE100797 (N) dataset. Comparison of CRRS of different CM patients in different response states after immunotherapy in phs000452 (C), PRJEB23709 (F), GSE91061 (I), GSE93157 (L), GSE100797 (O), GSE78220 (Q), and GSE106128 (S) dataset. *: P < 0.05; **: P < 0.01; ***: P < 0.001; ****: P < 0.0001

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us